Pharmacokinetic (PK) assessment of dacomitinib (D) in patients with locoregionally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through gastrostomy feeding tube (GT).
Joanne Wing-Yan Chiu
No relevant relationships to disclose
Kelvin K. Chan
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Pfizer
Eric Xueyu Chen
No relevant relationships to disclose
Albiruni R. A. Razak
Research Funding - Pfizer